Clinical trial · Observational
Florida Pancreas Collaborative Next Generation Biobank
The Florida Pancreas Collaborative Next-Generation Biobank: Reducing Health Disparities and Improving Survival for Pancreatic Cancer
NCT03851133CI-TRIAL-00116062active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is to partner with individuals known or suspected to have pancreatic cancer to build a biobank dedicated to minimizing disparities and personalizing care for individuals affected by pancreatic cancer. A biobank is a resource that involves collection, processing and storage of blood, other bodily fluids, and tissue.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Cachexia | Pancreatic Neoplasm | PROBABILISTIC | 0.70 |
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood Sample Collection | Other | — | UNRESOLVED |
| Data Collection | Other | — | UNRESOLVED |
| Tumor Sample collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- All Participants
- description
- Blood samples, tumor samples and data will be collected from all participants as applicable.
- interventionNames
- Other: Blood Sample Collection
- Other: Tumor Sample collection
- Other: Data Collection
Primary outcomes (5)
- measure
- Evidence of Precachexia
- timeFrame
- Up to 12 months
- description
- Cases will be evaluated for precachexia using the following guidelines: Anorexia with \<5% weight loss over past 6 months along with metabolic changes that together indicate precachexia.
- measure
- Evidence of Cachexia
- timeFrame
- Up to 12 months
- description
- Cases will be evaluated for cachexia using the following guidelines: Anorexia with \>5% weight loss over past 6 months, along with metabolic changes that together indicate cachexia.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18 years of age or older. * Patient presents for evaluation at a participating site with a strong clinical suspicion or diagnosis of a pancreatic cancer primary based on symptoms, imaging, biopsy, and/or blood-work and has not had treatment. * Patient self-reports as Non-Hispanic White, African American, or Hispanic. * Able to understand and voluntarily sign the informed consent. * Willing to complete study questionnaire(s) and donate medical images and biological specimens (including tissue and blood) obtained at the time of standard of care procedures (biopsy, surgery, and/or venipuncture) after signing the informed consent document. Exclusion Criteria: * No suspicion or diagnosis of pancreatic cancer. * Has a diagnosis of pancreatic cancer but and has already undergone treatment (which may include surgery, chemotherapy, and/or radiation). * Self-reported race/ethnicity other than Non-Hispanic White, African American, or Hispanic. * Unable to provide informed consent. * Unwilling to complete study questionnaires(s) and/or donate biological specimens
References
Publications (0)
Data not yet available
No reference posted for this study.